Pairwise comparisons of sprint measures between Nordic and sprint training groups. by Nicholas J. Ripley (14709756)

Subjects:

S1 Data - by Nicholas J. Ripley (14709756)

Subjects:

Mean (±95%CI) Rating of perceived exertion measured using a numeric scale (1–10) for the Nordic hamstring exercise, Sprint and control groups. by Nicholas J. Ripley (14709756)

Subjects:

Gardner-Altman estimation plots identifying Pre- and Post-intervention individual changes for 10-20m sprint time and Hedge’s <i>g</i> effect size with the 95% CI indicated by the e... by Nicholas J. Ripley (14709756)

Subjects:

Gardner-Altman estimation plots identifying Pre- and Post-intervention individual changes for peak net force and Hedge’s <i>g</i> effect size with the 95% CI indicated by the ends... by Nicholas J. Ripley (14709756)

Subjects:

Additional training performed by the NHE or sprint intervention groups across the seven-week training intervention, including sets x reps. by Nicholas J. Ripley (14709756)

Subjects:

Gardner-Altman estimation plots identifying Pre- and Post-intervention individual changes for relative peak eccentric hamstring force and Hedge’s <i>g</i> effect size with the 95%... by Nicholas J. Ripley (14709756)

Subjects:

Pairwise comparisons of eccentric hamstring measures for all training groups. by Nicholas J. Ripley (14709756)

Subjects:

Mean (±95%CI) 24-hr post soreness measured using a numeric pain rating scale (1–10) for the Nordic hamstring exercise, Sprint, and control groups. by Nicholas J. Ripley (14709756)

Subjects:

Gardner-Altman estimation plots identifying Pre- and Post-intervention individual changes for 0-10m sprint time and Hedge’s <i>g</i> effect size with the 95% CI indicated by the en... by Nicholas J. Ripley (14709756)

Subjects:

Gardner-Altman estimation plots identifying Pre- and Post-intervention individual changes for jump momentum and Hedge’s g effect size with the 95% CI indicated by the ends of the v... by Nicholas J. Ripley (14709756)

Subjects:

Discontinuous DEX PK raw data from repeated study. by Kavya Annu (11587215)

Subjects:

Kaplan-Meier curves for the effect of VD₃ sufficiency vs. deficiency on survival of mice from BCR-ABL Arf-/- leukemia. by Kavya Annu (11587215)

Subjects:

Plasma DEX concentrations in C57BL/6 VD₃ sufficient and deficient mice on a discontinuous DEX regimen. by Kavya Annu (11587215)

Subjects:

Serum 25(OH)VD3 levels in VD₃ sufficient and deficient mice. by Kavya Annu (11587215)

Subjects:

Cartoon depicting dexamethasone and dasatinib metabolism and efflux transport in intestine and liver. by Kavya Annu (11587215)

Subjects:

Differences in plasma and gut dexamethasone concentrations following the oral discontinuous DEX regimen leads to tissue specific activation of GCR and PXR. by Kavya Annu (11587215)

Subjects:

Gene expression (qPCR) data from livers of C57BL/6 mice before and after DEX treatment. by Kavya Annu (11587215)

Subjects:

Cyp and transporter gene expression in duodenum of VD₃ sufficient and deficient mice. by Kavya Annu (11587215)

Subjects:

Raw data from survival study in VD₃ sufficient vs. deficient male mice from BCR-ABL ALL when treated with dexamethasone. by Kavya Annu (11587215)

Subjects: